Clinical Trial Update: Development and Validation of a Post-operative Risk Of Local Recurrence Model Integrating Serology and Evalution (PROMISE) in Local Advanced Rectal Cancer Receiving Neoadjuvant Therapy: a Multicenter Study

View source ↗

Summary

A completed multicenter study validating PROMISE, a postoperative risk model that integrates serology and clinical evaluation to predict local recurrence in loc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Cai Zerong | Conditions: Locally Advanced Rectal Cancer (LARC) | Status: COMPLETED